Cardiovascular Effects of Noncardiovascular Drugs

被引：25

作者：

Raj, Satish R. ^{[1
,2
,3
]}

Stein, C. Michael ^{[1
,2
,3
]}

Saavedra, Pablo J. ^{[2
]}

Roden, Dan M. ^{[1
,2
,3
]}

机构：

[1] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37232 USA

[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA

[3] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA

来源：

CIRCULATION | 2009年 / 120卷 / 12期

基金：

美国国家卫生研究院;

关键词：

blood pressure; drugs; heart rate; long-QT syndrome; pharmacology; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CONGESTIVE-HEART-FAILURE; CORONARY-ARTERY-DISEASE; SUDDEN CARDIAC DEATH; TORSADE-DE-POINTES; MYOCARDIAL-INFARCTION; ANTIPSYCHOTIC-DRUGS; PROTEASE INHIBITORS; ATRIAL-FIBRILLATION; REVERSIBLE CARDIOMYOPATHY;

D O I：

10.1161/CIRCULATIONAHA.107.728576

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Most drugs are not used to treat heart disease. However, such "noncardiovascular" medications can often have cardiovascular effects. In this review, we discuss some cardiovascular manifestations of drugs used for noncardiovascular indications. We discuss these in the text according to the manifestations with which patients present; selected drugs are listed in Table 1 by their indication/drug class. The same medication may appear in different sections, reflecting the varied cardiovascular consequences of a particular drug. We also discuss cardiovascular effects of noncardiovascular drugs that arise indirectly from drug interactions that cause an increase or decrease in the concentration of a cardiovascular drug.

引用

页码：1123 / 1132

页数：10

共 123 条

[61] Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities [J].

Li, XQ ;

Andersson, TB ;

Ahlström, M ;

Weidolf, L .

DRUG METABOLISM AND DISPOSITION, 2004, 32 (08) :821-827

[62] Effectiveness of antipsychotic drugs in patients with chronic schizophrenia [J].

Lieberman, JA ;

Stroup, TS ;

McEvoy, JP ;

Swartz, MS ;

Rosenheck, RA ;

Perkins, DO ;

Keefe, RSE ;

Davis, SM ;

Davis, CE ;

Lebowitz, BD ;

Severe, J ;

Hsiao, JK .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) :1209-1223

[63] Thiazolidinediones and cardiovascular outcomes in older patients with diabetes [J].

Lipscombe, Lorraine L. ;

Gomes, Tara ;

Levesque, Linda E. ;

Hux, Janet E. ;

Juurlink, David N. ;

Alter, David A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (22) :2634-2643

[64] Zoledronic acid and clinical fractures and mortality after hip fracture [J].

Lyles, Kenneth W. ;

Colon-Emeric, Cathleen S. ;

Magaziner, Jay S. ;

Adachi, Jonathan D. ;

Pieper, Carl F. ;

Mautalen, Carlos ;

Hyldstrup, Lars ;

Recknor, Chris ;

Nordsletten, Lars ;

Moore, Kathy A. ;

Lavecchia, Catherine ;

Zhang, Jie ;

Mesenbrink, Peter ;

Hodgson, Patricia K. ;

Abrams, Ken ;

Orloff, John J. ;

Horowitz, Zebulun ;

Eriksen, Erik Fink ;

Boonen, Steven .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18) :1799-1809

[65] Estrogen plus progestin and the risk of coronary heart disease [J].

Manson, JE ;

Hsia, J ;

Johnson, KC ;

Rossouw, JE ;

Assaf, AR ;

Lasser, NL ;

Trevisan, M ;

Black, HR ;

Heckbert, SR ;

Detrano, R ;

Strickland, OL ;

Wong, ND ;

Crouse, JR ;

Stein, E ;

Cushman, M ;

Alving, B ;

Rossouw, JE ;

Pottern, L ;

Ludlam, S ;

McGowan, JA ;

Prentice, R ;

Anderson, G ;

LaCroix, A ;

Patterson, R ;

McTiernan, A ;

Cochrane, B ;

Hunt, J ;

Tinker, L ;

Kooperberg, C ;

McIntosh, M ;

Wang, CY ;

Chen, C ;

Bowen, D ;

Kristal, A ;

Stanford, J ;

Urban, N ;

Weiss, N ;

White, E ;

Shumaker, S ;

Rautaharju, P ;

Prineas, R ;

Naughton, M ;

Stein, E ;

Laskarzewski, P ;

Cummings, S ;

Nevitt, M ;

Dockrell, M ;

Harnack, L ;

Cammarata, F ;

Lindenfelser, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :523-534

[66] Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder [J].

Mbaya, Patrick ;

Alam, Faouzi ;

Ashim, Sindhu ;

Bennett, David .

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2007, 22 (03) :129-133

[67] Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial and comparison with national estimates from NHANES III [J].

McEvoy, JP ;

Meyer, JM ;

Goff, DC ;

Nasrallah, HA ;

Davis, SA ;

Sullivan, L ;

Meltzer, HY ;

Hsiao, J ;

Stroup, TS ;

Lieberman, JA .

SCHIZOPHRENIA RESEARCH, 2005, 80 (01) :19-32

[68]

Meadows M, 2001, FDA Consum, V35, P9

[69] CISPLATIN-INDUCED ATRIAL-FIBRILLATION [J].

MENARD, O ;

MARTINET, Y ;

LAMY, P .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) :192-193

[70] Atrial fibrillation associated with sumatriptan [J].

Morgan, DR ;

Trimble, M ;

McVeigh, GE .

BRITISH MEDICAL JOURNAL, 2000, 321 (7256) :275-275

← 2 3 4 5 6 7 8 9 10 11 →